267 related articles for article (PubMed ID: 21062982)
1. Critical roles of DMP1 in human epidermal growth factor receptor 2/neu-Arf-p53 signaling and breast cancer development.
Taneja P; Maglic D; Kai F; Sugiyama T; Kendig RD; Frazier DP; Willingham MC; Inoue K
Cancer Res; 2010 Nov; 70(22):9084-94. PubMed ID: 21062982
[TBL] [Abstract][Full Text] [Related]
2. Cooperation between Dmp1 loss and cyclin D1 overexpression in breast cancer.
Zhu S; Mott RT; Fry EA; Taneja P; Kulik G; Sui G; Inoue K
Am J Pathol; 2013 Oct; 183(4):1339-1350. PubMed ID: 23938323
[TBL] [Abstract][Full Text] [Related]
3. Repression of Dmp1 and Arf transcription by anthracyclins: critical roles of the NF-kappaB subunit p65.
Taneja P; Mallakin A; Matise LA; Frazier DP; Choudhary M; Inoue K
Oncogene; 2007 Nov; 26(53):7457-66. PubMed ID: 17546045
[TBL] [Abstract][Full Text] [Related]
4. Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancer.
Inoue K; Fry EA
Int J Cancer; 2016 Jul; 139(1):33-41. PubMed ID: 26802432
[TBL] [Abstract][Full Text] [Related]
5. Dmp1α inhibits HER2/neu-induced mammary tumorigenesis.
Fry EA; Taneja P; Maglic D; Zhu S; Sui G; Inoue K
PLoS One; 2013; 8(10):e77870. PubMed ID: 24205004
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu.
Fry EA; Taneja P; Inoue K
Int J Cancer; 2017 Feb; 140(3):495-503. PubMed ID: 27553713
[TBL] [Abstract][Full Text] [Related]
7. Mutually exclusive inactivation of DMP1 and ARF/p53 in lung cancer.
Mallakin A; Sugiyama T; Taneja P; Matise LA; Frazier DP; Choudhary M; Hawkins GA; D'Agostino RB; Willingham MC; Inoue K
Cancer Cell; 2007 Oct; 12(4):381-94. PubMed ID: 17936562
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer.
Maglic D; Zhu S; Fry EA; Taneja P; Kai F; Kendig RD; Sugiyama T; Miller LD; Willingham MC; Inoue K
Oncogene; 2013 Aug; 32(35):4120-9. PubMed ID: 23045280
[TBL] [Abstract][Full Text] [Related]
9. A p53/ARF-dependent anticancer barrier activates senescence and blocks tumorigenesis without impacting apoptosis.
Sinha VC; Qin L; Li Y
Mol Cancer Res; 2015 Feb; 13(2):231-8. PubMed ID: 25253740
[TBL] [Abstract][Full Text] [Related]
10. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K
Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189
[TBL] [Abstract][Full Text] [Related]
12. DMP1β, a splice isoform of the tumour suppressor DMP1 locus, induces proliferation and progression of breast cancer.
Maglic D; Stovall DB; Cline JM; Fry EA; Mallakin A; Taneja P; Caudell DL; Willingham MC; Sui G; Inoue K
J Pathol; 2015 May; 236(1):90-102. PubMed ID: 25537728
[TBL] [Abstract][Full Text] [Related]
13. [Overexpression of HER2/neu downregulates wild p53 protein expression via PI3K and Ras/Raf/MEK/ERK pathways in human breast cancer cells].
Zheng L; Ren JQ; Zhang L; Chen Q; Zhu HG
Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):358-62. PubMed ID: 15363324
[TBL] [Abstract][Full Text] [Related]
14. [The effect of HER2/neu overexpression on p53 gene expression, cell proliferation and sensitivity to gamma-irradiation via the PI3K/Akt pathway in breast cancer cell MCF7].
Zheng L; Ren JQ; Chen Q; Zhang HP; Zhu HG
Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):594-7. PubMed ID: 15634518
[TBL] [Abstract][Full Text] [Related]
15. Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16 Ink4a loss.
Debies MT; Gestl SA; Mathers JL; Mikse OR; Leonard TL; Moody SE; Chodosh LA; Cardiff RD; Gunther EJ
J Clin Invest; 2008 Jan; 118(1):51-63. PubMed ID: 18060046
[TBL] [Abstract][Full Text] [Related]
16. Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1).
Obata M; Imamura E; Yoshida Y; Goto J; Kishibe K; Yasuda A; Ogawa K
Mol Carcinog; 2001 Sep; 32(1):9-18. PubMed ID: 11568971
[TBL] [Abstract][Full Text] [Related]
17. Signal transduction involving the dmp1 transcription factor and its alteration in human cancer.
Sugiyama T; Frazier DP; Taneja P; Kendig RD; Morgan RL; Matise LA; Lagedrost SJ; Inoue K
Clin Med Oncol; 2008; 2():209-19. PubMed ID: 21892281
[TBL] [Abstract][Full Text] [Related]
18. Egr-1 is required for neu/HER2-induced mammary tumors.
Oh S; Kim H; Nam K; Shin I
Cell Signal; 2018 May; 45():102-109. PubMed ID: 29408223
[TBL] [Abstract][Full Text] [Related]
19. The Arf-inducing transcription factor Dmp1 encodes a transcriptional activator of amphiregulin, thrombospondin-1, JunB and Egr1.
Mallakin A; Sugiyama T; Kai F; Taneja P; Kendig RD; Frazier DP; Maglic D; Matise LA; Willingham MC; Inoue K
Int J Cancer; 2010 Mar; 126(6):1403-16. PubMed ID: 19816943
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional up-regulation of Sox9 by NF-κB in endometrial carcinoma cells, modulating cell proliferation through alteration in the p14(ARF)/p53/p21(WAF1) pathway.
Saegusa M; Hashimura M; Suzuki E; Yoshida T; Kuwata T
Am J Pathol; 2012 Aug; 181(2):684-92. PubMed ID: 22698986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
